Celldex Therapeutics, Inc. 4
4 · Celldex Therapeutics, Inc. · Filed Jun 16, 2017
Insider Transaction Report
Form 4
Davis Thomas Andrew
Sr. VP & CMO
Transactions
- Award
Incentive Stock Option (right to buy)
2017-06-15+150,000→ 150,000 totalExercise: $2.32From: 2018-06-15Exp: 2027-06-15→ Common Stock (150,000 underlying)
Footnotes (2)
- [F1]Represents option granted by the Issuer pursuant to its 2008 Stock Option and Incentive Plan.
- [F2]25% vest on June 15, 2018 and the remainder vest quarterly (in equal amounts) over the subsequent 12 quarters.